Contraception Flashcards

1
Q

The menstrual cycle is regulated by

A

positive and negative feedback in the hypothalamic–pituitary–ovarian axis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gonadotropin-releasing hormone (GnRH) pulses regulate

A

follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn, regulate the secretion of estrogen and progesterone from the ovary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The menstrual cycle is divided into

A

four phases: follicular, ovulatory, luteal, and menstrual.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Follicular phase: FSH stimulates

A

several follicles to develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

several follicles to develop

A

estradiol to create negative feedback and decrease FSH levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ovulatory phase: estradiol levels peak

A

and exert positive feedback to induce an LH surge, which facilitates release of the mature ovum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Estrogen promotes proliferation

A

of the endometrium and development of progesterone receptors in the endometrium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Luteal phase:

A

progesterone prevents new follicle development as well as differentiation of the endometrium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If no pregnancy, the

A

corpus luteum degenerates, leading to menstrual bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Use the safest, best-tolerated, and most

A

effective method that the patient desires.
Safety
Tolerance
Effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rational Drug Selection

A

Start with absolute contraindications.

Delivery method should be of patient’s choice.

Fine tune based on:
Menstrual pattern
Side-effect profile

Consider:
Patient’s desire for discretion
Timing of subsequent pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Steps in choice and initiation

A

establish rapport
identify those appropriate to receive contraceptive

counseling
assess medical history and contraindication to methods
initiate contraceptive

counseling process
elicit informed preferences for method characteristics
facilitate preference-

concordant decision making
counsel about method initiation and use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

World Health Organization Medical Eligibility Criteria for Contraception Use
US Medical Eligibility Criteria for Conception Use
Provide definitive guidance on safety across a broad range of conditions for different patient populations
Both label contraceptive methods as

A

category 1, 2, 3, or 4 for each identified condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Categories 1 and 2 are considered

A

generally safe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Category 4 methods are

A

contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For those classified as category 3,

A

the recommendations state that the “method is usually not recommended unless other more appropriate methods are not available or acceptable.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Contraception Methods

A

Combined hormonal contraceptives
Progestin-only contraceptives
Intrauterine devices
Emergency contraceptive pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Estrogen has positive effects on

A

bone mass, increases serum triglycerides, and improves ratio of high-density lipoprotein to low-density lipoprotein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Estrogen stimulates

A

coagulation and fibrinolyticpathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Progesterone increases

A

body temperature and insulin levels.

21
Q

Progesterone may depress

A

the central nervous system

22
Q

Two formulations of estrogen are available in contraceptive

A

ethinyl estradiol and mestranol

23
Q

Progestins are primarily responsible

A

for the contraceptive effect.

24
Q

Progestins exhibit a

A

egative effect in the hypothalamic-pituitary-ovarian axis.

25
Q

Progestins cause atrophy

A

of the endometrium, preventing implantation.

26
Q

The estrogen component improves

A

efficacy by suppressing FSH release.

27
Q

Estrogen provides

A

cycle control

28
Q

Traditional

A

21 days active drug + 7 days inactive tablets with withdrawal bleed during inactive tablets

29
Q

Extended cycle

A

84 days of active drug, then 7 days off

Withdrawal bleed once every 3 months

30
Q

Monophasic: same dose

A

of estrogen and progestin for full cycle

31
Q

Biphasic: vary

A

the dose of progestin

32
Q

Triphasic: vary the dose

A

of estrogen, progestin, or both

33
Q

Ortho Evra patch: releases

A

20 mcg of estrogen and 150 mcg of norelgestromin

34
Q

Patch applied weekly

A

for 3 weeks, then 1 week off

35
Q

start patch on

A

on first day of menses

Can start other days if back up method is used

36
Q

Topical Patch ADR

A

ADRs similar to OC ADRs

37
Q

Topical Patch increased

A

failure rate in women weighing more than 198 lb

38
Q

NuvaRing is a

A

a soft, flexible plastic ring that releases 15 mcg of estrogen and 120 mcg of etonogestrel daily.

39
Q

Ring is placed in the

A

vagina, left in place for 3 weeks, and then is left off for 1 week.

40
Q

ring has better

A

Better cycle control and decreased breakthrough bleeding are achieved compared with OC.

41
Q

ring systemic exposure

A

Systemic exposure to estrogen is lower.

42
Q

Progestin-Only Pills - these are used when

A

These are used when estrogen is contraindicated

43
Q

Progestin-Only Pills effeict is through

A

Contraceptive effect is through thickening of cervical mucus and prevention of sperm penetration.

44
Q

Progestin-Only Pills useres have to be diligent

A

Users have to be diligent about taking dose daily at the same time.
If a pill is taken even a few hours late, a back-up method is recommended for the following 48 hours

45
Q

Progestin-Only Pills ADR

A

ADRs: changing bleeding patterns and breast tenderness are common.

46
Q

Depot medroxyprogesterone acetate (Depo-Provera) is a

A

long-acting, injectable progestin-only contraceptive.

47
Q

Depot - One injection

A

One injection is effective in suppressing ovulation for 12 to 13 weeks

48
Q

Depot Advantages

A

Once every 12 week dosing

Effective

49
Q

Depot - Disadvantages

A

Spotting, followed by amenorrhea
Weight gain
Depression
Black Box warning: decreased bone density with longer-term use